Phase II study of stereotactic radiosurgery with volumetric modulated arc therapy for small lung cancer

Phase II study of stereotactic radiosurgery with volumetric modulated arc therapy for small lung cancer - Stereotactic radiosurgery for small lung cancer

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000022855

Enrollment

Registered

2016-07-27

Start date

2016-07-27

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

primary lung cancer, metastatic lung cancer

Interventions

Perform stereotactic radiosurgery with volumetric modulated arc therapy for small lung cancer

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1.Pathologically or clinically diagnosed primary lung cancer or solitary metastatic lung cancer. 2.tumor diameter:5 cm >= 3.tumor located 1cm away from chaest wall 4.tumor located 2cm away from organ at risk 5.forced expiratory volume 1.0:700 mL <= 6.Performance status(ECOG):0-2 7.medically inoperable or patient who refused surgery 8.written informed consent

Exclusion criteria

Exclusion criteria: 1. no serious diabetes, collagen disease, cardiac disease, pulmonary disease, kidney disease and psychological disorder 2.Single lung 3.receiving home oxygen therapy 4. pregnant or lactating woman, likelihood of pregnancy 5. active infectious disease 6. implanted pacemaker or implantable cardioverter defibrillator 7. no history of thoracic radiation therapy

Design outcomes

Primary

Measure	Time frame
3-year in-field tumor control rate	—

Secondary

Measure	Time frame
3-year overall survival time 3-year marginal failure rate Adverse event	—

Countries

Japan

Contacts

Public ContactSee above See above

See above See above

t.yamamoto@rad.med.tohoku.ac.jp+81-22-717-7312

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026